Agreements reached under this partnership
Business Alliances- 1
The companies will jointly sell some of the powdered culture media manufactured by our company.
- 2
The companies will jointly sell some of the ready-to-use culture media manufactured by 極東製薬工業.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The companies aim to begin selling approximately 25 ready-to-use culture media products manufactured by 極東製薬工業 in spring 2027.
The impact of this matter on our consolidated earnings forecast for the current fiscal year is minor.
| Item | Details |
|---|---|
| Name of alliance partner | 極東製薬工業株式会社 |
| Alliance partner's location | Chuo-ku, Tokyo |
| Type of alliance | Business Alliances |
| Details of the alliance | The companies will jointly sell some of the powdered culture media manufactured by our company., The companies will jointly sell some of the ready-to-use culture media manufactured by 極東製薬工業. |
| Numerical targets under the alliance | The companies aim to begin selling approximately 25 ready-to-use culture media products manufactured by 極東製薬工業 in spring 2027. |
| Impact on Business Performance | The impact of this matter on our consolidated earnings forecast for the current fiscal year is minor. |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As testing needs become more sophisticated and diverse and the importance of stable supplies to medical and testing institutions increases, the companies aim to complement each other's strengths, enhance supply stability, improve operating efficiency, and maintain and enhance the value they provide to customers.